Independent
Friday June 01 2012 A commonly-used drug to control Type 2 diabetes could double the risk of bladder cancer, a study indicates. Academics found pioglitazone, used to control blood sugar levels, increased the risk, but a comparable drug called...
PharmaGossip
Writing online in the British Medical Journal, the researchers, from the Jewish General Hospital in Montreal, Canada, said their results "provide evidence that pioglitazone is associated with an increased risk of bladder". They noted that in absolute...